Extracellular Vesicles as Drug Delivery System for the Treatment of Neurodegenerative Disorders : Optimization of the Cell Source
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
---|---|
Enthalten in: |
Advanced NanoBiomed Research - 3(2023), 6 |
Beteiligte Personen: |
Haney, Matthew J. [VerfasserIn] |
---|
Anmerkungen: |
© 2023 Wiley‐VCH GmbH |
---|
Umfang: |
1 |
---|
doi: |
10.1002/anbr.202300047 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
WLY014972557 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | WLY014972557 | ||
003 | DE-627 | ||
005 | 20231111123736.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231111s2023 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1002/anbr.202300047 |2 doi | |
028 | 5 | 2 | |a 2023-11-11_ANBR_2023_3_6.zip.xml |
035 | |a (DE-627)WLY014972557 | ||
035 | |a (WILEY)ANBR202300047 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
100 | 1 | |a Haney, Matthew J. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Extracellular Vesicles as Drug Delivery System for the Treatment of Neurodegenerative Disorders |b Optimization of the Cell Source |
264 | 1 | |c 2023 | |
300 | |a 1 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © 2023 Wiley‐VCH GmbH | ||
700 | 1 | |a Zhao, Yuling |4 aut | |
700 | 1 | |a Fallon, John K. |4 aut | |
700 | 1 | |a Wang, Yue |4 aut | |
700 | 1 | |a Li, Samuel M. |4 aut | |
700 | 1 | |a Lentz, Emily E. |4 aut | |
700 | 1 | |a Erie, Dorothy |4 aut | |
700 | 1 | |a Smith, Philip C. |4 aut | |
700 | 1 | |a Batrakova, Elena V. |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Advanced NanoBiomed Research |g 3(2023), 6 |w (DE-627)WLY001706144 |x 26999307 |7 nnns |
773 | 1 | 8 | |g volume:3 |g year:2023 |g number:6 |g extent:1 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_WLY | ||
951 | |a AR | ||
952 | |d 3 |j 2023 |e 6 |g 1 |